While in T-cell acute lymphoblastic leukemia/lymphoma the use of Gamma-secretase inhibitor was well tolerated, in Alzheimer patients used to decrease the production of Amyloid Beta precursor protein, which is involved in the pathogenesis of this disease, problems with tolerability and side effects have been reported [35,36]. Here, APP is linked to T-cell acute lymphoblastic leukemia.